000 | 01449 a2200433 4500 | ||
---|---|---|---|
005 | 20250515085842.0 | ||
264 | 0 | _c20071113 | |
008 | 200711s 0 0 eng d | ||
022 | _a1421-9662 | ||
024 | 7 |
_a10.1159/000108583 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKemna, Erwin H J M | |
245 | 0 | 0 |
_aNitric oxide does not contribute to inflammation-induced hypoferremia in humans. _h[electronic resource] |
260 |
_bActa haematologica _c2007 |
||
300 |
_a149-52 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnemia, Iron-Deficiency _xblood |
650 | 0 | 4 |
_aAntimicrobial Cationic Peptides _xurine |
650 | 0 | 4 |
_aCytokines _xblood |
650 | 0 | 4 |
_aEndotoxemia _xblood |
650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGuanidines _xadministration & dosage |
650 | 0 | 4 | _aHepcidins |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xblood |
650 | 0 | 4 |
_aIron _xblood |
650 | 0 | 4 |
_aLipopolysaccharides _xtoxicity |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNitric Oxide _xblood |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xantagonists & inhibitors |
700 | 1 | _aPickkers, Peter | |
700 | 1 | _aTjalsma, Harold | |
700 | 1 | _aSwinkels, Dorine W | |
773 | 0 |
_tActa haematologica _gvol. 118 _gno. 3 _gp. 149-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000108583 _zAvailable from publisher's website |
999 |
_c17403384 _d17403384 |